drugset / Trial / NCT01011296
First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers
RandomizedParallel-groupDouble-blindOther
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-04427429 administered intravenously to healthy adult volunteers.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04427429 | Unknown | 0.2 mg | Intravenous |
| Subject | PF-04427429 | Unknown | 1 mg | Intravenous |
| Subject | PF-04427429 | Unknown | 3 mg | Intravenous |
Indications
No indication recorded.